Sophia Genetics SA

NASDAQ SOPH

Download Data

Sophia Genetics SA Equity Repurchase (Common, Net) for the quarter ending March 31, 2024

Sophia Genetics SA Equity Repurchase (Common, Net) is NA for the quarter ending March 31, 2024. Equity Repurchase (Common, Net) represents the net cash flow from repurchasing or issuing common shares of the company.
NASDAQ: SOPH

Sophia Genetics SA

CEO Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date July 23, 2021
Location Switzerland
Headquarters Rue du Centre 172, Saint-Sulpice, Switzerland, 1025
Employees 430
Sector Healthcare
Industry Health information services
Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Similar companies

FORA

Forian Inc

NA

NA

MDRX

Veradigm Inc.

NA

NA

SLP

Simulations Plus Inc

NA

NA

PINC

Premier Inc

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email